Federated Hermes, Inc. Arvinas, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 134,210 shares of ARVN stock, worth $2.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

134,210

Previous 176,352 23.9%

Holding current value

$2.56 Million

Previous $4.69 Million 29.59%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.66 - $32.73 $997,079 - $1.38 Million	-42,142 Reduced 23.9%	134,210 $3.31 Million
Q2 2024 Aug 08, 2024	BUY	$24.46 - $40.4 $107,354 - $177,315	4,389 Added 2.55%	176,352 $4.69 Million
Q1 2024 May 14, 2024	BUY	$36.38 - $52.31 $1.23 Million - $1.78 Million	33,935 Added 24.59%	171,963 $7.1 Million
Q4 2023 Jan 31, 2024	BUY	$14.19 - $42.33 $479,196 - $1.43 Million	33,770 Added 32.39%	138,028 $5.68 Million
Q3 2023 Nov 13, 2023	BUY	$19.64 - $28.21 $2.05 Million - $2.94 Million	104,258 New	104,258 $2.05 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $18,572 - $32,741	572 Added 35.35%	2,190 $74,000
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $125 - $173	3 Added 0.19%	1,618 $72,000
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $58,084 - $119,749	1,613 Added 80650.0%	1,615 $68,000
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $723 - $978	-12 Reduced 85.71%	2 $1,000
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $3,950 - $5,772	-60 Reduced 81.08%	14 $1,000
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $3.33 Million - $4.91 Million	-45,502 Reduced 99.84%	74 $6,000
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $961,759 - $1.34 Million	-15,910 Reduced 25.88%	45,576 $3.51 Million
Q1 2021 May 13, 2021	BUY	$58.19 - $91.37 $3.18 Million - $4.99 Million	54,648 Added 799.18%	61,486 $4.06 Million
Q4 2020 Feb 12, 2021	SELL	$20.19 - $84.93 $151,647 - $637,909	-7,511 Reduced 52.35%	6,838 $581,000
Q3 2020 Nov 12, 2020	SELL	$22.99 - $36.34 $264,660 - $418,346	-11,512 Reduced 44.51%	14,349 $339,000
Q2 2020 Aug 13, 2020	SELL	$29.88 - $56.74 $4.88 Million - $9.26 Million	-163,283 Reduced 86.33%	25,861 $867,000
Q1 2020 May 13, 2020	BUY	$33.0 - $54.5 $6.24 Million - $10.3 Million	189,044 Added 189044.0%	189,144 $7.62 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $1,539 - $4,438	100 New	100 $4,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Arvinas, Inc. Transaction History